Accuray Incorporated
- Jurisdiction
United States - LEI
549300G28LY4TZKZJG51 - ISIN
US0043971052 (ARAY )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
6
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
6
/ 7
Profile
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. Read full profile
Fundamentals
- Net revenue
€391.08M - Gross margin
32.1% - EBIT
€6.69M - EBIT margin
1.7% - Net income
-€1.36M - Net margin
-0.3%
Statement period: - (published )
Products
| Product | Revenue | |
|---|---|---|
| Product |
| |
| Service |
|
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Earnings Calls
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| Peter Brown |
|
|
|
Sell |
Earnings Calls
Latest earnings call: May 1, 2024 (Q3 2024)